Arbutus Biopharma Corp Preferred Stock, Value, Issued
Arbutus Biopharma Corp (ABUS) had Preferred Stock, Value, Issued of $66.27 million as of 2018-06-30, per its 10-Q filed 2018-08-03.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:PreferredStockValue · last filed 2018-08-03
- 2018-06-30: Preferred Stock, Value, Issued $66.27M.
- 2018-03-31: Preferred Stock, Value, Issued $66.27M.
- 2017-12-31: Preferred Stock, Value, Issued $48.87M.
| Period end | Preferred Stock, Value, Issued |
|---|---|
| 2018-06-30 | $66.27M 10-Q · filed 2018-08-03 |
| 2018-03-31 | $66.27M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $48.87M 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |